Valneva SE VLA.PA
FR · Euronext Paris · XPAR · stock · Healthcare · website
Valneva SE statistics & valuation
Market cap€502.4M
P / S2.9×
P / B4.7×
Net margin-66.0%
Return on equity-108.5%
FCF margin-32.8%
Net debt€97.6M
Enterprise value USD$691.6M
Earnings yield EBIT/EV-13.6%
Return on capital-26.7%
Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 38.7% | 41.9% | 34.4% | 10.2% |
| Operating margin | -46.7% | -45.9% | -53.4% | -31.4% |
| Net margin | -66.0% | -7.2% | -66.0% | -39.7% |
| FCF margin | -32.8% | -49.3% | -141.2% | -76.0% |
| Return on assets | -28.9% | -2.4% | -22.0% | -23.1% |
| Return on equity | -108.5% | -6.8% | -79.1% | -65.2% |
| Debt / equity | 1.52× | 0.92× | 1.04× | 0.40× |
| Current ratio | 2.38 | 2.61 | 1.65 | 1.53 |
Computed from company filings · FR · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.